207 related articles for article (PubMed ID: 8358553)
1. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.
McMurdo L; Lidbury PS; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Jun; 109(2):530-4. PubMed ID: 8358553
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous receptors mediate endothelin-1-induced changes in blood pressure, hematocrit, and platelet aggregation.
McMurdo L; Lidbury PS; Corder R; Thiemermann C; Vane JR
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S185-8. PubMed ID: 7509940
[TBL] [Abstract][Full Text] [Related]
3. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat.
Filep JG; Clozel M; Fournier A; Földes-Filep E
Br J Pharmacol; 1994 Nov; 113(3):845-52. PubMed ID: 7858876
[TBL] [Abstract][Full Text] [Related]
4. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
5. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
6. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
7. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.
McMurdo L; Corder R; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Feb; 108(2):557-61. PubMed ID: 8448603
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
[TBL] [Abstract][Full Text] [Related]
9. The endothelin ETB receptor agonist, IRL 1620, causes vasodilatation and inhibits ex vivo platelet aggregation in the anaesthetised rabbit.
McMurdo L; Thiemermann C; Vane JR
Eur J Pharmacol; 1994 Jun; 259(1):51-5. PubMed ID: 7957593
[TBL] [Abstract][Full Text] [Related]
10. Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065.
Battistini B; Warner TD; Fournier A; Vane JR
Br J Pharmacol; 1994 Apr; 111(4):1009-16. PubMed ID: 8032583
[TBL] [Abstract][Full Text] [Related]
11. Selective blockade of endothelin receptor subtypes on systemic and renal vascular responses to endothelin-1 and IRL1620, a selective endothelin ETB-receptor agonist, in anesthetized rats.
Matsuura T; Yukimura T; Kim S; Miura K; Iwao H
Jpn J Pharmacol; 1996 Jul; 71(3):213-22. PubMed ID: 8854203
[TBL] [Abstract][Full Text] [Related]
12. Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1995 May; 115(2):227-36. PubMed ID: 7670725
[TBL] [Abstract][Full Text] [Related]
13. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of endothelin (ET-1) induced pressor responses by the endothelin (ETA) receptor antagonist FR139317 in the pithed rat.
Sun XY; Hedner T; Feng Q; Edvinsson L
Blood Press; 1992 Aug; 1(2):108-12. PubMed ID: 1366258
[TBL] [Abstract][Full Text] [Related]
15. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
McMurdo L; Thiemermann C; Vane JR
Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
[TBL] [Abstract][Full Text] [Related]
16. Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.
Cristol JP; Warner TD; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Mar; 108(3):776-9. PubMed ID: 8467364
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.
Sogabe K; Nirei H; Shoubo M; Nomoto A; Ao S; Notsu Y; Ono T
J Pharmacol Exp Ther; 1993 Mar; 264(3):1040-6. PubMed ID: 8450448
[TBL] [Abstract][Full Text] [Related]
18. The in vivo antiaggregatory action of endothelin-1 is not mediated through the endothelin ETA receptor.
Hermán F; Yano M; Filep JG
Eur J Pharmacol; 1993 May; 236(1):143-6. PubMed ID: 8319738
[TBL] [Abstract][Full Text] [Related]
19. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
Allcock GH; Warner TD
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
